Kalyanasundaram Subramanian, or Kal Sundaram, an old hand at Sun Pharmaceutical Industries, is coming back home. He will be leading the India and sub-continent business starting January 2017.
Pharmaceutical company Suven Life Sciences has been granted a patent each by India and South Africa for a drug used in treatment of neuro-degenerative diseases.
Kalyanasundaram Subramanian, or Kal Sundaram, an old hand at Sun Pharmaceutical Industries, is coming back home. He will be leading the India and sub-continent business starting January 2017. Post the acquisition of Ranbaxy, Sun has taken the top rank in India, with a market share of 8.7%. The decision to bring back Sundaram from Taro Pharmaceutical Industries, the money-spinning unit of Sun Pharma, signals a move that’s possibly aimed at shaping the next stage of growth for India’s largest drugmaker, analysts and industry experts said.
Scientists, including one of Indian-origin, have developed a new technology to observe the back of the eye and detect Alzheimer’s before the onset of symptoms, an advance that may help diagnose the debilitating disease early. Clinical trials are to start in this month to test the technology in humans, researchers said. The research builds upon previous work in cells by detecting changes in the retina of mice predisposed to develop Alzheimer’s.
The Medicines Patent Pool (MPP), a United Nations- backed public health organisation working to increase access to HIV viral he patitis- C and tuberculosis treatments in low and middle-income countries, has signed manufacturing licences with six Indian pharmaceutical companies to produce generic versions of antiretro virals and hepatitis-C antiviral. The companies include Aurobindo Pharma, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila, besides a Chinese company Desano, for a total of nine sub-licensing agreements.
With corporate employees spending 60-70% of their time in offices, workplace health is not an option or a benefit but a necessity. Large firms are beginning to play a larger role as far as the well-being of their workforce is concerned, but the country is not investing on preventive care, panellists said at the fifth Mint Healthcare Conclave in Mumbai on 17 June. Not doing so will mean enormous costs in terms of illness and insurance claims, they warned.
Sun Pharma has announced that effective August 2016, Abhay Gandhi will take over as CEO, North America Business. Kal Sundaram will assume the position of CEO-India business and emerging markets.
Opto Circuits (India) Ltd has announced that wholly owned subsidiary, Eurocor Gmbh, launchesCoated Shunt Balloon Catheter, used for DIALYSIS patients which reduces re-intervention and preserves future treatment options.
Beginning this week, BD, the medical technology brand will work with diabetes management hospital professionals in Columbia Asia hospitals across India, for a period of nine months through its BD Getting Started program.
The Central TB division (CTD), Ministry of Health & Family Welfare, the North Maharashtra University (NMU) together with The International Union against Tuberculosis and Lung Disease (The Union) and United States Agency for International Development (USAID) organized a research and academia conclave in the city.
Apollo Hospitals announced that it recently signed a MoU with Stanford University for the Stanford South Asian Translational Heart Initiative (SAATHI) related to South Asians and Chronic Disease.
Kalyanasundaram Subramanian, or Kal Sundaram, an old hand at Sun Pharmaceutical Industries, is coming back home. He will be leading the India and sub-continent business starting January 2017. Post the acquisition of Ranbaxy, Sun has taken the top rank in India, with a market share of 8.7%. The decision to bring back Sundaram from Taro Pharmaceutical Industries, the money-spinning unit of Sun Pharma, signals a move that’s possibly aimed at shaping the next stage of growth for India’s largest drugmaker, analysts and industry experts said.
Scientists, including one of Indian-origin, have developed a new technology to observe the back of the eye and detect Alzheimer’s before the onset of symptoms, an advance that may help diagnose the debilitating disease early. Clinical trials are to start in this month to test the technology in humans, researchers said. The research builds upon previous work in cells by detecting changes in the retina of mice predisposed to develop Alzheimer’s.
The Medicines Patent Pool (MPP), a United Nations- backed public health organisation working to increase access to HIV viral he patitis- C and tuberculosis treatments in low and middle-income countries, has signed manufacturing licences with six Indian pharmaceutical companies to produce generic versions of antiretro virals and hepatitis-C antiviral. The companies include Aurobindo Pharma, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila, besides a Chinese company Desano, for a total of nine sub-licensing agreements.
With corporate employees spending 60-70% of their time in offices, workplace health is not an option or a benefit but a necessity. Large firms are beginning to play a larger role as far as the well-being of their workforce is concerned, but the country is not investing on preventive care, panellists said at the fifth Mint Healthcare Conclave in Mumbai on 17 June. Not doing so will mean enormous costs in terms of illness and insurance claims, they warned.
Sun Pharma has announced that effective August 2016, Abhay Gandhi will take over as CEO, North America Business. Kal Sundaram will assume the position of CEO-India business and emerging markets.
Opto Circuits (India) Ltd has announced that wholly owned subsidiary, Eurocor Gmbh, launchesCoated Shunt Balloon Catheter, used for DIALYSIS patients which reduces re-intervention and preserves future treatment options.
Beginning this week, BD, the medical technology brand will work with diabetes management hospital professionals in Columbia Asia hospitals across India, for a period of nine months through its BD Getting Started program.
The Central TB division (CTD), Ministry of Health & Family Welfare, the North Maharashtra University (NMU) together with The International Union against Tuberculosis and Lung Disease (The Union) and United States Agency for International Development (USAID) organized a research and academia conclave in the city.
Apollo Hospitals announced that it recently signed a MoU with Stanford University for the Stanford South Asian Translational Heart Initiative (SAATHI) related to South Asians and Chronic Disease.
No comments:
Post a Comment